Does Intermittent Nutrition Enterally Normalise hormonal and metabolic responses to feeding in critically ill adults? The DINE-Normal proof-of-concept study
Abstract
Background and aims
For intensive care unit (ICU) patients fed via a nasogastric (NG) tube, current guidelines recommend continuous feeding through the day and night. Emerging evidence in healthy individuals shows that NG feeding in an intermittent diurnal pattern promotes phasic hormonal, digestive and metabolic responses vital for effective nutrition, though this has not been studied in the critically ill population. This proof-of-concept study aimed to compare the effect of diurnal intermittent versus continuous enteral feeding on hormonal and metabolic outcomes in ICU patients.
Methods
We conducted a single-centre, randomised, open-label trial in the ICU. Adult ICU patients that were anticipated to require NG feeding for >48 hours were randomised to an intermittent diurnal regimen (feeds at 8:00, 13:00 and 18:00), or continuous feeding with equivalent nutritional value, for 48 hours. The primary outcome was peak plasma insulin within 3 hours of delivering the first intermittent feed on the second study day, compared to the same time period in the continuous group. Secondary outcomes included feasibility, tolerability and metabolic profiles.
Results
Thirty patients were randomised to intermittent (n=13) or continuous (n=17) feeding. Two patients in the intermittent group were excluded from analysis (1 required jejunal feeding, 1 withdrew consent). Peak plasma insulin concentrations (mean ± SD) were significantly higher in the intermittent group (373 ± 204pmol/L) versus continuous (58 ± 41pmol/L, p<0.001). Peak plasma glucose concentrations (mean ± SD) also differed in the intermittent and continuous groups, respectively (10.6 ± 2.5mmol/L versus 8.4 ± 2.4mmol/L, p=0.04). There were no other statistically significant between-group differences.
Conclusion
Intermittent diurnal feeding, compared to continuous feeding, preserves the physiological insulin response in critically ill adults. Both regimens were well tolerated, supporting the need for a larger trial to assess other clinically important patient-centred outcomes.
Trial Registration
This trial was registered prospectively at<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov">clinicaltrials.gov</ext-link>(study ID<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="clintrialgov" xlink:href="NCT06115044">NCT06115044</ext-link>).
Related articles
Related articles are currently not available for this article.